IOVS Molecular Human Reproduction
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Streilein, J. W.
Right arrow Articles by Niederkorn, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Streilein, J. W.
Right arrow Articles by Niederkorn, J. Y.

Investigative Ophthalmology & Visual Science, Vol 23, 489-500, Copyright © 1982 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Heterotopic corneal grafting in mice: a new approach to the study of corneal alloimmunity

JW Streilein, J McCulley and JY Niederkorn

Heterotopic grafting of murine corneas to the thoracic cage of recipient mice affords an opportunity to study the alloimmune rejection process in this well-characterized laboratory species. Immune rejection of cornea allografts can be reliably identified by direct visual, slit- lamp, and histologic observations. Virtually intact syngeneic corneal epithelium and stroma survive at the heterotopic site for at least 21 days. Allogeneic corneal epithelium is destroyed by an intense fibrovascular infiltrative process. If Descemet's membrane is preserved, integrity of the stroma and epithelium of syngeneic corneal grafts is preserved, whereas when this membrane is broken, progressive stromal deterioration sets in. This property of Descemet's membrane is particularly apparent in allogeneic corneal grafts.


This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
J Plskova, L Kuffova, V Holan, M Filipec, and J V Forrester
Evaluation of corneal graft rejection in a mouse model
Br. J. Ophthalmol., January 1, 2002; 86(1): 108 - 113.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Hori, N. C. Joyce, and J. W. Streilein
Immune Privilege and Immunogenicity Reside among Different Layers of the Mouse Cornea
Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3032 - 3042.
[Abstract] [Full Text]


Home page
IOVSHome page
Y. Sano, B. R. Ksander, and J. W. Streilein
Langerhans Cells, Orthotopic Corneal Allografts, and Direct and Indirect Pathways of T-Cell Allorecognition
Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1422 - 1431.
[Abstract] [Full Text]


Home page
IOVSHome page
J. Hori, N. Joyce, and J. W. Streilein
Epithelium-Deficient Corneal Allografts Display Immune Privilege beneath the Kidney Capsule
Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 443 - 452.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the Association for Research in Vision and Ophthalmology